foxo4-dri peptide senolytic 2023 2024 study The disordered p53 transactivation domain

SKU: 46186706429

Pay in 4 interest-free payments of $6.53 Learn more

Live Spec

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications foxo4 dri senolytic 2023 2024 study Molecular modelling of the FOXO4 TP53 interaction to design peptides for the elimination of senescent cancer cells Development of a novel senolytic FOXO4 DRI part 1 #peptide #molecule #research #health #information Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI: A Breakthrough Peptide Targeting Aging at Its Roots PARTICLE, s. r. o. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC

Store: vanlokventuinen.nl · Domain: vanlokventuinen.nl